Panhandle Nuclear Pharmacy is categorized under Wholesale Pharmaceutical Products in Amarillo, TX and active since 1993.
Panhandle Nuclear Pharmacy was established in 1993, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Stanley J Britten at the company’s single location by writing to 6700 Sw 9th Avenue, Amarillo, Texas TX 79106 or by phoning (806) 352-9561. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Panhandle Nuclear Pharmacy |
Contact Person: | Stanley J Britten |
Address: | 6700 Sw 9th Avenue, Amarillo, Texas 79106 |
Phone Number: | (806) 352-9561 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1993 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 4461100 |
Share This Business: |
Panhandle Nuclear Pharmacy was started in 1993 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Stanley J Britten for inquiries that concern Panhandle Nuclear Pharmacy by calling the company number (806) 352-9561, as your correspondence is most welcome. Additionally, the physical location of the single location of Panhandle Nuclear Pharmacy can be found at the coordinates 35.20603,-101.91125 as well as the street address 6700 Sw 9th Avenue in Amarillo, Texas 79106.
For its online presence, you may visit Panhandle Nuclear Pharmacy’s website at and engage with its social media outlets through on Twitter and on Facebook.